Latest News
- Min. Nadda Unveils ?13,000-Crore Bio-Pharma SHAKTI and Chemical Parks Push to Expand India’s Global Chemicals and Biologics Footprint
- Aurobindo Pharma Subsidiary Launches Generic Cancer Drug in US, Expands Oncology Portfolio in Global Generics Market
- KIMS Hospitals Introduces Adaptive Deep Brain Stimulation in India for Advanced Parkinson’s Treatment
Delhi Drugs Control Department Cracks Down on Regulatory Violations in Mehrauli, 26 Firms Booked
Authorities uncovered regulatory lapses at 26 firms, ranging from documentation discrepancies to licensing issues, prompting the initiation of legal proceedings against them. In a proactive quality-control measure, the department also collected 265 samples of medicines for laboratory testing to verify safety and authenticity before they continue circulating in the market.
- By Newsdesk
- New Delhi
- Dec 23, 2025
In a decisive enforcement action aimed at safeguarding public health, the Delhi Drugs Control Department carried out a large-scale inspection of pharmaceutical outlets in the Mehrauli area on Monday, taking strict action against 26 firms found breaching drug regulations.
Acting on directives to clamp down on irregularities in the distribution and sale of medicines, drug control officials visited 37 retail and wholesale establishments in the bustling South Delhi neighbourhood. During the operation, teams scrutinised records and storage practices to ensure compliance with the Drugs and Cosmetics Act and associated rules.
Authorities uncovered regulatory lapses at 26 firms, ranging from documentation discrepancies to licensing issues, prompting the initiation of legal proceedings against them. In a proactive quality-control measure, the department also collected 265 samples of medicines for laboratory testing to verify safety and authenticity before they continue circulating in the market.
Delhi Health Minister Pankaj Singh emphasised that the campaign reflects the government’s “zero-tolerance” stance on the sale of substandard or unauthorised drugs, underscoring that ongoing enforcement drives will be conducted across the capital to ensure that residents have access to safe and effective medications. He said similar inspections will be expanded to other localities as part of a broader effort to uphold regulatory standards and protect consumers.
Officials affirmed that such actions are essential to maintain integrity in the pharmaceutical supply chain, protect patients from potential harm, and strengthen monitoring mechanisms across the city.